A Comparison of the Pharmacological Profile of AT7519 in Solid Tumour and Haematological Cell Lines. Author(s) MS Squires, R E Feltell, V Lock, D Smith, EJ Lewis, J Higgins, M Yule, D M Cross, NT Thompson, JF Lyons - Protein P16 - Document - PDFSEARCH.IO

First Page	Meta Content
	A Comparison of the Pharmacological Profile of AT7519 in Solid Tumour and Haematological Cell Lines. Author(s) MS Squires, R E Feltell, V Lock, D Smith, EJ Lewis, J Higgins, M Yule, D M Cross, NT Thompson, JF Lyons Add to Reading List Document Date: 2012-12-13 18:06:00 Open Document File Size: 150,88 KB Share Result on Facebook City Ovarian Carcinoma / / Company JF Lyons Astex Therapeutics Ltd. Ltd. / / Currency pence / / MedicalCondition substrates Retinoblastoma / B-Cell lymphoproliferative disorders / leukaemia line / Colon Carcinoma / contrast leukaemia cell lines / leukaemia cell line / leukaemia cell / HCT116 tumours / Leukaemia Lymphoma MOLT4 / MS / Tumour / leukaemia cell lines / / Person Milton Cambridge / / Position Author / Balb/c Nu/Nu Mouse Model control Control Q8hx2 / / ProvinceOrState Aurora / / PublishedMedium GRANTA / / Technology apoptosis / / URL www.astex-therapeutics.com / / SocialTag Proteins Retinoblastoma protein Cyclin Apoptosis CDK inhibitor Cell cycle checkpoint Protein P16 Biology Cell biology Cell cycle

A Comparison of the Pharmacological Profile of AT7519 in Solid Tumour and Haematological Cell Lines. Author(s) MS Squires, R E Feltell, V Lock, D Smith, EJ Lewis, J Higgins, M Yule, D M Cross, NT Thompson, JF LyonsAdd to Reading List